We identify potential investments through deep sector research and assess our capability in full partnership with their management teams to build market-leading and innovative companies.
2022
Laboratoire X.O is a leading pan-European distributor of over-the-counter drugs across various therapeutic areas.
2022
Qinecsa is a leading global provider of pharmacovigilance software and outsourced services to support its global pharma customers across their clinical safety and PV commitments.
2020
Noden Pharma DAC is a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas in international markets. The company focuses its resources on acquiring and optimizing established medicines.
2020
Essential is a portfolio company of a European focused private equity fund. Simon Cottle led the origination of the investment in the company and was co-lead on the execution of the transaction